FDA Sued For Yanking Approval Of Generic Chemo Drug
The U.S. Food and Drug Administration illegally revoked Lannett Co. Inc.'s abbreviated new drug application for the chemotherapy drug temozolomide without due process after it was allegedly granted by mistake, the generic...To view the full article, register now.
Already a subscriber? Click here to view full article